Syndax Pharmaceuticals
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
3
Funding Rounds
$65.6m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** M. Ev*** | - | - | - |
| Mi***** Do**** | - | - | - |
| Pe*** Or******** | - | - | - |
| Ri***** A. He**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Wi***** Me*** | - | - | - |
| Pi**** Le***** | - | - | - |
| Ke*** A. Ka**** | - | - | - |
| De**** Po****** | - | - | - |
| Mi***** A. Me***** | - | - | |
| Je****** Ja***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Syndax Pharmaceuticals has raised a total of $65.6m in funding over 3 rounds.
Key Insights:
- Syndax Pharmaceuticals Corporate funding round Funding Round 2020: $30m
- Syndax Pharmaceuticals Series B round: $26.6m
- Syndax Pharmaceuticals Series A round: $9m
Syndax Pharmaceuticals Corporate funding round Funding Round 2020
$30m
Syndax Pharmaceuticals Series B round
$26.6m
Syndax Pharmaceuticals Series A round
$9m
Industries
Syndax Pharmaceuticals is active in the following industries:
- Oncology
- Biomedical engineering
- Biology
- Technology
- Biotechnology
- Engineering
- Immunotherapy
- Cancer immunotherapy